The tariff and trade policy changes that made 2025 so tumultuous for pharmaceutical companies are shaping up to bring benefits in the year ahead now that there’s more clarity, according to manufacturers at the annual …
Read More from Endpoints News
Manufacturers benefit as pharma customers invest back in US
